Dr. Farid Badria

Mansoura University, Egypt

Prof. Badria got his B. Sc. in Pharmaceutical Sciences, Mansoura University, Egypt, Two M. Sc. In Pharmacognosy (Chemistry of Natural Products), Mansoura University, Egypt and M. Sc. In Pharmacognosy (Pharm. Cell Biology), University of Minnesota, USA and Ph.D in Pharmacognosy (Biotransformation), University of Mississippi, USA. Farid has an outstanding academic records of accomplishments towards his University, country, and the African union. Subsequently Prof. Badria was recognized at both national and international levels; Masoura recognition medical award 2006, State Recognition Award in Medicine (Egyptian Academy of Science) 2001, Outstanding Arab Scholar, Kuwait (2000), Khawrazmi International Award, Presented by Iranian President, Iran (2000), Merit of First Class from the President of Egypt (1998), State Recognition Award in Medicine (Egyptian Academy of Science), 1996, Mansoura University Recognition Award in Pharmaceutical sciences(Mansoura University) 1996, Food and Drugs Administration, 1998 (FDA, Arab Development Fund, Kuwait (2000), ICRO-UNESCO International, Chile (1999), UNESCO Biotechnology Fellowship, France (1994), Honorary Fellowship, University of Mississippi, USA (1987-90). Cooperation of Prof. Badria with several African countries was presented in forms of Projects in the area of Nephropathy and mycotoxins (Monasteur, Tunise, with Prof. Hasan Bacha, 1996), Lectures and workshops (Dakar, Sengal, HCV workshop 2005), Algeria (Training, MS. Hewetta, 2009). Prof. Badria utilized his extensive experience in the areas of Chemistry of Natural Products (U. of Mansoura (Egypt), and Mississippi, USA, Biology (U of Minnesota, USA), Molecular biology (U. Mainz, Germany), and Medical and clinical (U. Roma, Italy) to develop potential agents and/or drugs to help fight endemic diseases among African community (e.g Schistosomiasis, Hepatitis, fatty liver, parasites). Over 100 publications, several patents, and many innovative techniques documented the concerted efforts by Prof. Badria to serve Egyptian and international communities. Some of very important accomplishments may be summarized as follows: - Sixteen Approved patents: Currently 5 products are in the pipelines in Pharmaceutical firms for treatment of: Hepatitis, Schistosomiasis, Colitis, Osteoarthritis. - Utilization of available natural economic resources: Most of raw materials used in developing new therapeutic agents were obtained from our own natural sources. - Bridging gaps between University, Industry, and community. - Emphasizing on the role of research and innovation in improving economy, health, and welfare of society.



  • 1971 – 1973

    Samanoud High School, Samanoud

  • 1984 - 1986

    Pharmacy, University of Minnesota, Minneapolis

    Medicinal Chemistry

  • 1986 – 1990

    Pharmacy, University of Mississippi, Oxford


Edited Books

  • Evidence-based Strategies in Herbal Medicine, Psychiatric Disorders and Emergency Medicine

    This book intends to strike a balance between developments in pharmacotherapy research and the facts that researchers must absorb, as well as link scientific advances with clinical practice so that the management of diseases can be based on sound physiological concepts. Each chapter has been reviewed and new authors have brought up-to-date research to make the book more informative, illustrative, and easy to read. The book focuses on three major areas: Experimental, preclinical, and clinical applications of herbal medicine; Evidence-based strategies in emergency medicine and New approach in management of psychiatric disorders. The first three chapters describe new and modern applications of common herbs for treatment of several inflammatory and skin disorders, e.g. ulcerative colitis, bronchial asthma, osteoarthritis, multiple sclerosis, and melasma. Chapter four deals with the most severe hypertensive states that pose an immediate threat to life, and how to manage these situations. The fifth chapter is dedicated to tackling polypharmacy psychiatric disorders. We hope this book is useful to a wide range of readers, from students first learning about pharmacotherapy, through advanced clinicians and researchers who are looking for a review of current treatments and conceptualizations of the condition. It is our hope that this book may motivate readers to approach the evidence on pharmacotherapy with an open mind, and thereby spark an interest in initiating further contributions to the current scientific debate and treatment development efforts.

  • Pharmacotherapy

    The intent of this book is to provide an overview of current conceptualizations of Pharmacotherapy. The book focuses on three major areas; diagnosis, treatment, and prevention for a wide array of diseases; Cognitive and Psychological disorders (Schizophrenia and Nicotine addiction), Inflammatory disorders (New Chemical anti-inflammatory and Immunotherapy), updated antihypertensive therapy and healing of ulcers with venous origin. A separate chapter is dedicated to the rationality of drug use in earthquake injuries. The last chapter deals with Imaging of potential therapeutic or diagnostic agents in animal models in the early stage of research. We hope this book is useful to a wide range of people, from students first learning about Pharmacotherapy, to advanced clinicians and researchers.